| 1 |
34841717 | Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors. | 2022 Jan |
1 |
| 2 |
33422061 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity. | 2021 Jan 9 |
1 |
| 3 |
33500617 | Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin. | 2021 |
2 |
| 4 |
34128757 | Real-world experience with trabectedin for the treatment of recurrent ovarian cancer. | 2021 Oct |
1 |
| 5 |
32399300 | The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan. | 2020 |
1 |
| 6 |
31008727 | Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer. | 2019 Jul |
1 |
| 7 |
28365224 | Design and evaluation of a phospholipase D based drug delivery strategy of novel phosphatidyl-prodrug. | 2017 Jul |
1 |
| 8 |
28700899 | Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer. | 2017 Sep 10 |
3 |
| 9 |
26089893 | Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D. | 2015 |
1 |
| 10 |
26093057 | Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. | 2015 Oct |
2 |
| 11 |
22902994 | Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts. | 2013 Jul 1 |
1 |
| 12 |
23388584 | A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it? | 2013 Feb 6 |
1 |
| 13 |
23419527 | Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. | 2013 Jul 10 |
3 |
| 14 |
23863745 | [A case of recurrent endometrial carcinoma with pleural effusion maintained long SD by pegylated liposomal doxorubicin(PLD)chemotherapy]. | 2013 Jul |
2 |
| 15 |
24335366 | [Safety and efficacy of pegylated liposomal Doxorubicin and Carboplatin on platinum-sensitive recurrent epithelial ovarian cancer]. | 2013 Dec |
1 |
| 16 |
20352294 | Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer. | 2011 Oct |
1 |
| 17 |
18701868 | [Doxil--pegylated liposomal doxorubicin]. | 2008 Aug |
3 |
| 18 |
17251657 | Primary cardiac angiosarcoma. | 2006 |
1 |
| 19 |
15289836 | Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review). | 2004 Sep |
1 |
| 20 |
15717735 | Advantages of liposomal delivery systems for anthracyclines. | 2004 Dec |
3 |
| 21 |
15717736 | Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. | 2004 Dec |
2 |
| 22 |
15717739 | Liposomal anthracycline treatment for ovarian cancer. | 2004 Dec |
1 |
| 23 |
15717740 | The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer. | 2004 Dec |
1 |
| 24 |
15717742 | Cardiac safety of liposomal anthracyclines. | 2004 Dec |
1 |
| 25 |
15717744 | Pharmacoeconomics of liposomal anthracycline therapy. | 2004 Dec |
1 |
| 26 |
20945566 | Doxorubicin-loaded poly(ethylene oxide)-trimellitic anhydride chloride-folate superparamagnetic iron oxide nanoparticles | 2004 |
3 |
| 27 |
12736762 | A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma. | 2003 May |
1 |
| 28 |
11750714 | Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial. | 2002 Jan |
2 |
| 29 |
10811504 | Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study. | 2000 Mar |
1 |